Cargando…

Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq

BACKGROUND: Optimal prescribing of secondary prevention medications after acute coronary syndrome (ACS) events has been shown to reduce morbidity and mortality. However, it is unknown whether these medications are optimally prescribed at discharge from acute care in Iraq. OBJECTIVE: To evaluate whet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nassr, Ola A., Forsyth, Paul, Johnson, Chris F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463406/ https://www.ncbi.nlm.nih.gov/pubmed/31015874 http://dx.doi.org/10.18549/PharmPract.2019.1.1372

Ejemplares similares

Evaluation of Blood Pressure Control and Associated Factors among Patients with Hypertension in Iraq: A Prospective Cross-sectional Study
por: Nassr, Ola Ali, et al.
Publicado: (2019)

Adherence to guidelines for the prescription of secondary prevention medication at hospital discharge after acute coronary syndrome: a multicentre study
por: Tra, J., et al.
Publicado: (2015)

Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the community
por: Johnson, Chris F., et al.
Publicado: (2018)

Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge
por: Lee, Helen Y., et al.
Publicado: (2008)

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Present and future of secondary prevention after an acute coronary syndrome
por: Keller, Pierre-Frederic, et al.
Publicado: (2011)

Use of medicines recommended for secondary prevention of acute coronary syndrome
por: Gaedke, Mari Ângela, et al.
Publicado: (2015)

Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
por: Berger, Jeffrey S.
Publicado: (2018)

Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand
por: Redfern, Julie, et al.
Publicado: (2014)

Evaluation of Antibiotic Prophylaxis and Discharge Prescriptions in the General Surgery Department
por: Karaali, Cem, et al.
Publicado: (2019)

Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden
por: Begum, Najida, et al.
Publicado: (2015)

Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study
por: Chow, Clara K, et al.
Publicado: (2019)

Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome
por: Fitchett, David H., et al.
Publicado: (2020)

Correction: Evaluation of Antibiotic Prophylaxis and Discharge Prescriptions in the General Surgery Department
por: Karaali, Cem, et al.
Publicado: (2019)

Quality Improvement Project to Evaluate Discharge Prescriptions in Children With Cystic Fibrosis
por: Merino Sanjuán, Matilde, et al.
Publicado: (2019)

Changing the Landscape of Secondary Prevention After Acute Coronary Syndrome: Morphology, Physiology, or Both?
por: Otake, Hiromasa
Publicado: (2022)

Acute Coronary Syndrome Secondary to Aortocaval Fistula
por: Cruz-Utrilla, Alejandro, et al.
Publicado: (2019)

Are there gender differences in acute management and secondary prevention of acute coronary syndromes in Barbados? A cohort study
por: Sobers, Natasha, et al.
Publicado: (2019)

Medication Literacy in a Cohort of Chinese Patients Discharged with Acute Coronary Syndrome
por: Zhong, Zhuqing, et al.
Publicado: (2016)

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
por: Husted, Steen
Publicado: (2015)

Dropping risk stratification with subsequent treatment-risk paradox in non ST elevation acute coronary syndromes: a clinical audit in Iraq
por: Dakhil, Zainab Atiyah, et al.
Publicado: (2021)

Prevalence of Antidepressant Prescription or Use in Patients with Acute Coronary Syndrome: A Systematic Review
por: Czarny, Matthew J., et al.
Publicado: (2011)

Trend of vaccine preventable diseases in Iraq in time of conflict
por: Lafta, Riyadh, et al.
Publicado: (2018)

Comparative Evaluation of MRSA Nasal Colonization Epidemiology in the Urban and Rural Secondary School Community of Kurdistan, Iraq
por: Hussein, Nawfal R., et al.
Publicado: (2015)

Polio Outbreak Response; Evaluation of Acute Flaccid Paralysis Surveillance in Karbala, Iraq
por: Aradhi, Abdulkareem A. Mahmood, et al.
Publicado: (2020)

Betaine and Secondary Events in an Acute Coronary Syndrome Cohort
por: Lever, Michael, et al.
Publicado: (2012)

Application of MAT Methodology in the Evaluation of Prescribing Adherence to Clinical Practice Guidelines for Secondary Prevention of Coronary Heart Disease in Post-Acute Coronary Syndrome Patients in Kuwait
por: Al-Taweel, Dalal, et al.
Publicado: (2021)

Yamaguchi syndrome: A mimicer of acute coronary syndrome
por: Ruhela, Manish, et al.
Publicado: (2022)

Evaluation of proper prescribing of cardiac medications at hospital discharge for patients with acute coronary syndromes (ACS) in two Lebanese hospitals
por: Sheikh-Taha, Marwan, et al.
Publicado: (2014)

Religious practices and long-term survival after hospital discharge for an acute coronary syndrome
por: Abu, Hawa O., et al.
Publicado: (2019)

Predictors allowing early discharge after interventional treatment of acute coronary syndrome patients
por: Bauer, Dávid, et al.
Publicado: (2022)

Predicting Statin Adherence Following Hospital Discharge for Acute Coronary Syndromes: What’s the Score?
por: Barlow, Thomas R., et al.
Publicado: (2023)

Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets
por: Silverio, Angelo, et al.
Publicado: (2023)

Suboptimal Utilization of Secondary Drug Prevention in Acute Coronary Syndrome: Measurement Issues and Managed Care Opportunities
por: Quilliam, Brian J.
Publicado: (2008)

Discharge prescription patterns of opioid and nonopioid analgesics after common surgical procedures
por: Nooromid, Michael J., et al.
Publicado: (2018)

Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?
por: Pereira, Pradeep, et al.
Publicado: (2017)

DELAYED PRESENTATION OF ACUTE CORONARY SYNDROME SECONDARY TO COVID-19
por: SHAKERIAN, B., et al.
Publicado: (2022)

Safety and cost analysis of early discharge following percutaneous coronary intervention for acute coronary syndrome in patients with diabetes mellitus
por: Li, Shihong, et al.
Publicado: (2019)

Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications
por: Auer, Reto, et al.
Publicado: (2014)

Effect and safety of antithrombotic therapies for secondary prevention after acute coronary syndrome: a network meta-analysis
por: Mo, Fanrui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5nj3o46rk8th69dbet3lc1075e